Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what’s right, not what’s easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,400 generic and branded pharmaceuticals, including antiretroviral therapies on which nearly 50% of people being treated in the developing world depend. We market our products in approximately 165 countries and territories. Our global R&D and manufacturing platform includes more than 50 facilities, and we are one of the world’s largest producers of active pharmaceutical ingredients. Every member of our more than 30,000-strong workforce is dedicated to creating better health for a better world, one person at a time.

The Ashray program was created by Mylan India to increase awareness about hepatitis C and breast cancer in India. The programs by Ashray are managed by independent third party consultants who are HIPPA compliant which include Indegene Life systems Pvt Ltd for Breast cancer awareness and Sarathi Healthcare Pvt Ltd for Hepatitis C to offer treatments with medication and counselling.

We care about patients and their families. The Ashray program helps patients and their families understand and manage the illness and provide deeper insights into various issues through holistic solutions.

Our mission is to provide 7 billion people access to high quality medicine. We provide patient support programs that offer solutions for breast cancer and hepatitis C.

At Mylan, we have developed solutions for holistic medical care that follow global quality standards. We nurture the emotional and physological needs of patients and their families through counselling programs implemented by trained multi-lingual counsellors.